Nonthermal Biocompatible Plasma Inactivation of Coronavirus SARS-CoV-2: Prospects for Future Antiviral Applications

Nonthermal Biocompatible Plasma Inactivation of Coronavirus SARS-CoV-2: Prospects for Future Antiviral Applications

The coronavirus disease (COVID-19) pandemic has placed a massive impact on global civilization. Finding effective treatments and drugs for these viral diseases was crucial. This paper outlined and highlighted key elements of recent advances in nonthermal biocompatible plasma (NBP) technology for ant...

Full description

Bibliographic Details
Main Authors: Ihn Han, Sohail Mumtaz, Eun Ha Choi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Viruses
Subjects:
nonthermal plasma
COVID-19
SARS-CoV-2
NBP viral inactivation
coronavirus disinfection
Online Access:https://www.mdpi.com/1999-4915/14/12/2685

Similar Items

Similar Items